OMNIA™ · HTA intelligence engine
Source-linked answers from 10,000+ HTA reports across ten national agencies, with analogue sets, an agentic assistant and a JCA readiness scorecard.
Outcomes & Market Navigation through Intelligent Analytics
01
Ten agencies, ten formats, ten vocabularies. Reading them one report at a time does not scale to a portfolio.
02
Analogue sets built by memory and by hand miss the precedent that decides the case.
03
A summary without its source cannot be defended in a dossier or a negotiation. Access decisions need the sentence, not the paraphrase.
Coverage
Ten national agencies in one searchable record, 1,200+ drugs, all therapeutic areas. Markets: USA, Canada, EU-5, Sweden, Australia, Brazil and Argentina, plus JCA reports. Products not yet in the record are compiled on request, within hours.
The four workflows
01
Each decision dated, carrying its agency's own verdict fields; one column per drug and country, so agencies are compared, not just products.
02
Within class, outside the class and adjacent areas, screened across the corpus in seconds, with market access criteria applied.
03
Searches all ten agencies with no report preselected, cites the sentence behind each answer, and drafts access deliverables including GVD, IEP and PVN.
04
Scores the evidence package, surfaces the fatal flaws that cap the band, ranks the fixes before the review window opens.
Every extracted value opens the source report at the sentence it was read from.
Answers carry their evidence, and the evidence carries its agency and its date. That is the difference between an intelligence engine and a chatbot over public PDFs.
Built for senior teams that need speed without sacrificing rigor. Project based, subscription, or licensed users for teams working in the platform directly.
Book a demoOr leave details and the team will reach out within one business day.
Frequently asked
OMNIA is the HTA intelligence engine of VantEdge Access: a searchable record of 10,000+ HTA reports from ten national agencies, covering 1,200+ drugs across all therapeutic areas. It returns source-linked answers, builds analogue sets, drafts access deliverables and scores JCA readiness, so evidence work moves in hours rather than weeks.
Ten agencies in one record: HAS, G-BA, AIFA, AEMPS, TLV, ICER, CDA-AMC, PBAC, CONITEC and CONETEC, covering the USA, Canada, the EU-5, Sweden, Australia, Brazil and Argentina, plus JCA reports. Products not yet in the record are compiled on request, within hours.
Provenance. Every extracted value opens the source report at the sentence it was read from, with the agency's own verdict fields and the decision date. Answers are traceable to the payer's wording rather than to a summary, which is what an access dossier or a negotiation has to withstand.
A structured score of an evidence package against the Joint Clinical Assessment requirements. It surfaces the fatal flaws that cap the achievable band, ranks the fixes by impact, and does so before the review window opens, when changes to the package are still possible.
Three ways, depending on the need: project based for a single decision, subscription for continuous intelligence, or licensed users for teams working in the platform directly. Delivery is senior-led throughout in every model; the platform supports the advisers rather than replacing them.